| Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples J Bullard, K Dust, D Funk, JE Strong, D Alexander, L Garnett, C Boodman, ... Clinical Infectious Diseases 71 (10), 2663-2666, 2020 | 1459 | 2020 |
| Successful treatment of Ebola virus–infected cynomolgus macaques with monoclonal antibodies X Qiu, J Audet, G Wong, S Pillet, A Bello, T Cabral, JE Strong, F Plummer, ... Science translational medicine 4 (138), 138ra81-138ra81, 2012 | 410 | 2012 |
| Stability of SARS-CoV-2 on critical personal protective equipment SB Kasloff, A Leung, JE Strong, D Funk, T Cutts Scientific reports 11 (1), 1-7, 2021 | 193 | 2021 |
| mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms X Qiu, G Wong, L Fernando, J Audet, A Bello, J Strong, JB Alimonti, ... Science translational medicine 5 (207), 207ra143-207ra143, 2013 | 162 | 2013 |
| N95 mask decontamination using standard hospital sterilization technologies A Kumar, SB Kasloff, A Leung, T Cutts, JE Strong, K Hills, ... MedRxiv, 2020 | 97 | 2020 |
| Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice A Patel, Y Zhang, M Croyle, K Tran, M Gray, J Strong, H Feldmann, ... The Journal of infectious diseases 196 (Supplement_2), S413-S420, 2007 | 73 | 2007 |
| A single dose respiratory recombinant adenovirus-based vaccine provides long-term protection for non-human primates from lethal Ebola infection JH Choi, K Jonsson-Schmunk, X Qiu, DJ Shedlock, J Strong, JX Xu, ... Molecular pharmaceutics 12 (8), 2712-2731, 2015 | 69 | 2015 |
| Comparison analysis of different swabs and transport mediums suitable for SARS-CoV-2 testing following shortages L Garnett, A Bello, KN Tran, J Audet, A Leung, Z Schiffman, BD Griffin, ... Journal of virological methods 285, 113947, 2020 | 57 | 2020 |
| Pathogenicity comparison between the Kikwit and Makona Ebola virus variants in rhesus macaques G Wong, X Qiu, MA de La Vega, L Fernando, H Wei, A Bello, ... The Journal of infectious diseases 214 (suppl_3), S281-S289, 2016 | 36 | 2016 |
| Lassa fever: With 50 years of study, hundreds of thousands of patients and an extremely high disease burden, what have we learned? LE Garnett, JE Strong Current opinion in virology 37, 123-131, 2019 | 24 | 2019 |
| Ebola virus is unlikely to become endemic in West Africa A Sprecher, H Feldmann, LE Hensley, G Kobinger, ST Nichol, J Strong, ... Nature microbiology 1 (3), 1-2, 2016 | 4 | 2016 |
| Characterization of Marburg virus from a recent outbreak in Angola D Falzarano, F Feldmann, S Martin, J Geisbert, A Grolla, L Fernando, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 75 (5), 190-190, 2006 | | 2006 |
| 604. Comparative Analysis of Different Methods for Quantitative Evaluation of Neutralizing Antibody to Ebola Virus in a Biosafety Level 2 or 4 Environment H Ebihara, X Qiu, S Theriault, M Klassen, U Stroeher, J Strong, S Jones, ... Molecular Therapy 13, S233-S234, 2006 | | 2006 |
